KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 1.612
EU - Europa 702
AS - Asia 496
SA - Sud America 200
AF - Africa 47
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.060
Nazione #
US - Stati Uniti d'America 1.593
RU - Federazione Russa 197
BR - Brasile 187
SG - Singapore 172
HK - Hong Kong 167
IT - Italia 158
IE - Irlanda 104
CN - Cina 86
SE - Svezia 79
FR - Francia 39
GB - Regno Unito 34
CI - Costa d'Avorio 29
DE - Germania 27
IN - India 26
AT - Austria 19
NL - Olanda 13
CA - Canada 11
VN - Vietnam 10
PL - Polonia 8
MA - Marocco 7
BD - Bangladesh 6
TR - Turchia 6
FI - Finlandia 5
UA - Ucraina 5
ES - Italia 4
IQ - Iraq 4
MX - Messico 4
PK - Pakistan 4
PY - Paraguay 4
EU - Europa 3
JM - Giamaica 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
ZA - Sudafrica 3
AR - Argentina 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
MT - Malta 2
SA - Arabia Saudita 2
BE - Belgio 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
ID - Indonesia 1
JO - Giordania 1
JP - Giappone 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
NP - Nepal 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 3.060
Città #
Des Moines 380
Chandler 310
Hong Kong 165
Dublin 103
Boardman 95
Singapore 95
Ashburn 84
Fairfield 67
Moscow 41
Ancona 33
Lawrence 30
Princeton 30
Abidjan 29
San Mateo 28
Wilmington 28
The Dalles 26
Pune 25
Beijing 23
Los Angeles 21
Woodbridge 21
Seattle 19
Turin 19
Falls Church 18
Houston 17
Nuremberg 17
Cambridge 16
Marche 16
New York 14
São Paulo 14
Ann Arbor 13
Milan 13
Vienna 12
San Diego 11
Columbus 10
Washington 10
Rome 9
Rio de Janeiro 8
San Francisco 8
Shanghai 8
Dallas 7
Norwalk 7
Dong Ket 6
Falconara Marittima 6
Warsaw 6
Boston 5
Brasília 5
Campinas 5
London 5
Southwark 5
Amsterdam 4
Goiânia 4
Guangzhou 4
Ho Chi Minh City 4
Montesilvano Marina 4
Phoenix 4
Toronto 4
Andria 3
Aversa 3
Blumenau 3
Brooklyn 3
Buffalo 3
Chiswick 3
Curitiba 3
Frankfurt am Main 3
Istanbul 3
Jiaxing 3
Kingston 3
Lincoln 3
Montreal 3
Monza 3
Munich 3
Perugia 3
Ribeirão Preto 3
Santo André 3
Siena 3
Tashkent 3
Agrate Conturbia 2
Ankara 2
Apucarana 2
Belo Horizonte 2
Belém 2
Bragança Paulista 2
Brindisi 2
Cincinnati 2
Contagem 2
Copenhagen 2
Dhaka 2
Divinópolis 2
Fano 2
Fortaleza 2
Franca 2
Goianira 2
Guarulhos 2
Guayaquil 2
Hangzhou 2
Helsinki 2
Itabira 2
Juneau 2
Maceió 2
Makhachkala 2
Totale 2.079
Nome #
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 115
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 107
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 86
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 84
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 84
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 80
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 79
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 79
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 78
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 78
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 75
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 75
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 72
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 72
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 72
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 72
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 68
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 68
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 67
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 66
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 65
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 64
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 64
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 62
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 62
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 61
Cluster stability in the analysis of mass cytometry data 61
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 60
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 60
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 60
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 58
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 57
Natural born survivors: The inglorious TP53 47
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 44
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 39
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 34
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 34
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 33
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 32
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 32
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 30
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 28
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 27
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 27
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 26
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 24
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 24
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 23
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 23
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 21
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 21
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 21
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 20
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 20
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 20
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 19
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 19
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 19
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 18
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 17
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 16
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 15
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 15
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 14
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 14
Functional characterization of CD4+ T cells in aplastic anemia 13
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 13
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 13
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 12
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy 11
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 11
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 10
Totale 3.210
Categoria #
all - tutte 21.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.521


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 77 39
2021/2022331 2 79 0 1 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/20251.241 75 117 46 18 47 73 202 64 254 74 111 160
2025/202665 65 0 0 0 0 0 0 0 0 0 0 0
Totale 3.210